YUSRA SHABBIR: Open Payments
NPI 1376015941 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 20 payments from 9 companies in 2025. Trend: 2023 $121 · 2024 $513 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| PFIZER INC. | 3 | $50 |
| Novo Nordisk Inc | 3 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Bausch Health US, LLC | 2 | $38 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Verona Pharma, Inc. | 1 | $14 |
Products named: CAPLYTA, Ozempic, VOQUEZNA, APLENZIN, BREZTRI, ELIQUIS, VRAYLAR, JARDIANCE.
Industry payments across KY — which companies pay providers there.
